Now, we have seen the first real sign of hope in more than a decade: a stunning 14% decline in the national overdose death rate. But change is possible. At Boston Medical Center’s Grayken Center ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson & Johnson. The main ingredient for the ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.

There have not been specific studies on using OTC nasal spray products such as Afrin in people who are pregnant or breastfeeding. However, the product labels usually include warnings for people in ...

A doctor may prescribe ketorolac (Toradol), an NSAID available as a nasal spray, to help manage migraine attacks that cause severe pain. They may also recommend ketorolac as a rescue medication if ...

The University of New Brunswick has placed nasal spray naloxone kits around its campuses for emergency opioid overdose situations. The kits were already available in Saint John residences ...

“An overdose can happen to anyone. If you or someone you know uses opioids, having an OD safety kit on hand could save a life.” Each free OD safety kit contains a naloxone nasal ...

One of its small steps came Tuesday when the company revealed that it has gained exclusive commercial rights in the U.S. and Canada to Kloxxado, an emergency nasal spray for opioid overdose ...